Company Search:
Advanced Search
Sponsored Links
Cara Therapeutics Inc Company Snapshot
Cara Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cara Therapeutics Inc with three other companies in this sector in the United States: Boston Therapeutics Inc (2016 sales of $98,878.00 of which 100% was Sugardown TM), Clovis Oncology Inc ($78,000.00 of which 100% was Anti Cancer Medicines), and RegeneRx Biopharmaceuticals, Inc. ($93,308.00 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cara Therapeutics Inc
  Stock Performance Chart for Cara Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 12.69
(Figures in U.S. Dollars)
1 Week 1.2%   13 Weeks -0.2%  
4 Weeks 1.8%   52 Weeks 11.1%  
Cara Therapeutics Inc Key Data:
  Ticker: CARA Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 86,000
(Year Ending Jan 2017).
Employees: 34
  Currency: U.S. Dollars Market Cap: 413,801,675
  Fiscal Yr Ends: December Shares Outstanding: 32,608,485
  Share Type: Common Closely Held Shares: 1,601,722
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.